| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | rupatadine (Rupafin®) |
| Formulation | 10 mg tablet |
| Reference number | 586 |
| Indication | Treatment of allergic rhinitis and chronic idiopathic urticaria in adults and adolescents (over 12 years of age) |
| Company | GlaxoSmithKline |
| BNF chapter | Respiratory system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/08/2009 |